Join
Live feed
·
INSIDERFilingvia Quantisnow
NewAmsterdam Pharma Company N.V. logo

Director Mckenna Mark C. was granted 3,400 units of Ordinary Shares, increasing direct ownership by 49% to 10,360 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NAMS· NewAmsterdam Pharma Company N.V.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAMS (NewAmsterdam Pharma Company N.V.) and more on Quantisnow.